RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Evaluation of structural effects on 5-HT receptor antagonism by aporphines: Identification of a new aporphine with 5-HT antagonist activity
Ponnala, S., Gonzales, J., Kapadia, N., Navarro, H., & Harding, WW. (2014). Evaluation of structural effects on 5-HT receptor antagonism by aporphines: Identification of a new aporphine with 5-HT antagonist activity. Bioorganic and Medicinal Chemistry Letters, 24(7), 1664-1667. https://doi.org/10.1016/j.bmcl.2014.02.066
A set of aporphine analogs related to nantenine was evaluated for antagonist activity at 5-HT2A and alpha1A adrenergic receptors. With regards to 5-HT2A receptor antagonism, a C2 allyl group is detrimental to activity. The chiral center of nantenine is not important for 5-HT2A antagonist activity, however the N6 nitrogen atom is a critical feature for 5-HT2A antagonism. Compound 12b was the most potent 5-HT2A aporphine antagonist identified in this study and has similar potency to previously identified aporphine antagonists 2 and 3. The ring A and N6 modifications examined were detrimental to alpha1A antagonism. A slight eutomeric preference for the R enantiomer of nantenine was observed in relation to alpha1A antagonism